RetmarkerAMD Research

This new tool allows for a faster and more precise way to conduct a detailed analysis of the lesions associated the early and late forms of Age-related Maculopathy. It promotes the creation of a broad basis for the assertive discussion on the prognostic value of the different lesions found in this disease - Professor Rufino Silva, Principal Investigator of the Centre for Clinical Trials (CEC) at AIBILI

RetmarkerAMD Research was developed for an Epidemiological Study and makes use of Retmarker's image exploration features and adds very simple manual and preset annotation of Drusen (including confluence), Hypopigmentation, Hyperpigmentation, Geographic Atrophy and Exudative Lesions.

RetmarkerAMD Research automatically counts lesions (in number and area) by lesion type and location (sub-field), significantly reducing the time needed.

RetmarkerAMD simplifies the diagnostic by ophthalmologists, as they now have a more precise source of information, which is not prone to errors related to the complexity in the estimations of lesion areas present in each region of the colour fundus photographs.

Using the mouse or keyboard it is very easy and fast to document lesions (even confluent drusen).

Pre-set graphic annotation tools promote work streamline.

Automatic data by lesion type and location (total and per sub-field).

At the current moment both RetmarkerAMD Research and RetmarkerC (link) can be used in AMD patients and together they can be used to help evaluating each patient and monitor how they progress overtime.

RetmarkerAMD Research

You can access more information on this product version
by downloading the official brochure here.

If you are interested on the science behind RetmarkerAMD Research, please take a look at the Literature section.

For a detailed list of functionalities and benefits, please refer to the Features section.

RetmarkerC is a natural complement to RetmarkerAMD Research. For RetmarkerC, please click here or use the top menu.

You can always contact us to clarify any further doubt by using the Contacts form.